SOPHiA GENETICS SA
SOPH • NASDAQ
SOPHiA GENETICS SA is a medical - healthcare information services company in the healthcare sector trading on NASDAQ, led by CEO Jurgi Camblong, with a market cap of $336.8M.
CEOJurgi Camblong
Market Cap$336.8M
Medical - Healthcare Information Services
Healthcare
Employees449.0
Websitesophiagenetics.com
Next Earnings
Upcoming earnings announcement for SOPHiA GENETICS SA
Date
Tuesday, May 5, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.24
Revenue Estimate
$20.4M
Earnings History
Past 12 earnings reports for SOPHiA GENETICS SA
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Q4 2025 | -$0.28Est: -$0.20 | -40.0% | $21.7MEst: $20.9M | +3.9% | — |
| Nov 4, 2025 | Q3 2025 | -$0.30Est: -$0.20 | -50.0% | $19.5MEst: $18.1M | +7.4% | — |
| Aug 5, 2025 | Q2 2025 | -$0.33Est: -$0.17 | -94.1% | $18.3MEst: $17.4M | +5.5% | — |
| May 6, 2025 | Q1 2025 | -$0.26Est: -$0.19 | -36.8% | $17.8MEst: $16.8M | +6.1% | — |
| Mar 4, 2025 | Q4 2024 | -$0.23Est: -$0.15 | -53.3% | $17.7MEst: $17.7M | +0.1% | — |
| Nov 5, 2024 | Q3 2024 | -$0.28Est: -$0.23 | -21.7% | $15.9MEst: $15.9M | +0.0% | — |
| Aug 6, 2024 | Q2 2024 | -$0.23Est: -$0.28 | +17.9% | $15.8MEst: $17.4M | -9.1% | — |
| May 7, 2024 | Q1 2024 | -$0.21Est: -$0.27 | +22.2% | $15.8MEst: $15.6M | +1.1% | — |
| Mar 5, 2024 | Q4 2023 | -$0.37Est: -$0.27 | -37.0% | $17.0MEst: $17.3M | -1.6% | — |
| Nov 7, 2023 | Q3 2023 | -$0.21Est: -$0.31 | +32.3% | $16.3MEst: $15.6M | +4.3% | — |
| Aug 8, 2023 | Q2 2023 | -$0.33Est: -$0.29 | -13.8% | $15.1MEst: $15.1M | -0.3% | — |
| May 9, 2023 | Q1 2023 | -$0.26Est: -$0.32 | +18.8% | $14.0MEst: $13.9M | +0.5% | — |